It should also be noted VUL raised $200 million recently, yet still only appears to have around 130 million shares on issue. Raise was done at $13 level so very few shares issued. If Rce can get a big run in price while they still have lots of cash in the bank then any raise to fund phase 3 trials could be at a far higher level meaning existing holders n I t diluted like many billion share 5cent biotechs? Such great potential for an anti biotic that so far appears to cure all chronic burns infections within 7 days. Surely that has to be worth as much if not more than a bunch of lithium for car batteries?
the most incredible thing with Rce is the work they have done and the time they have been going, yet they have been able to maintain low shares on issue due to good cash management.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)